Analogic in the 2018 Global Diagnostic Imaging Sector

This strategic assessment of Analogic, one of the worlds leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from VPGMarketResearch.com presents a comprehensive analysis of the companys performance, capabilities, goals, and strategies in the global diagnostic imaging market. 

SECTION I: EXECUTIVE SUMMARY
 - A 3-15 page synopsis of key sections.

SECTION II: BUSINESS ORGANIZATION
 - History of the company’s diagnostic imaging business evolution, which is important to
   understanding the corporate culture, management mentality and strategies.
 - Recent acquisitions, divestitures and major organizational changes.
 - Current organizational structure.

SECTION III: SENIOR MANAGEMENT
 - Names, titles and background of key executives.

SECTION IV: FACILITIES AND EMPLOYEES
 - Administrative, manufacturing and R&D facilities in the U.S. and abroad.
 - Manufacturing practices.
 - New plants under construction.
 - The U.S. and international work force size and distribution.

SECTION V: TECHNOLOGICAL KNOW-HOW
 - Internally developed and acquired diagnostic imaging and related technologies, including
   X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.

SECTION VI: PRODUCT PORTFOLIO
 - Placements and installed base of major systems in the U.S. and abroad, by modality.
 - Review of major product lines.
 - Applications, advantages and weaknesses of leading products.

SECTION VII: MARKETING TACTICS
 - Promotional tactics.
 - Distribution approaches.
 - Product service and support.
 - Customer relations.

SECTION VIII: FINANCIAL ANALYSIS
 - Estimated sales and operating profit by division, geographic region and product line.
 - Five-year sales and operating profit performance.

SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
 - Estimated R&D budget.
 - Research facilities and staff.
 - New technologies, systems and applications in development.

SECTION X: COLLABORATIVE ARRANGEMENTS
 - Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
 - Terms of collaborative agreements and specific products involved.

SECTION XI: STRATEGIC DIRECTION
 - Specific business, new product development and marketing strategies. 
 - Anticipated acquisitions, joint ventures and divestitures.

Contains 49 pages and 5 tables

SECTION I: EXECUTIVE SUMMARY
- A 3-15 page synopsis of key sections.
SECTION II: BUSINESS ORGANIZATION
- History of the companys diagnostic imaging business evolution, which is important to understanding
the corporate culture, management mentality and strategies.
- Recent acquisitions, divestitures and major organizational changes.
- Current organizational structure.
SECTION III: SENIOR MANAGEMENT
- Names, titles and background of key executives.
SECTION IV: FACILITIES AND EMPLOYEES
- Administrative, manufacturing and R&D facilities in the U.S. and abroad.
- Manufacturing practices.
- New plants under construction.
- The U.S. and international work force size and distribution.
SECTION V: TECHNOLOGICAL KNOW-HOW
- Internally developed and acquired diagnostic imaging and related technologies, including X-ray,
ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.
SECTION VI: PRODUCT PORTFOLIO
- Placements and installed base of major systems in the U.S. and abroad, by modality.
- Review of major product lines.
- Applications, advantages and weaknesses of leading products.
SECTION VII: MARKETING TACTICS
- Promotional tactics.
- Distribution approaches.
- Product service and support.
- Customer relations.
SECTION VIII: FINANCIAL ANALYSIS
- Estimated sales and operating profit by division, geographic region and product line.
- Five-year sales and operating profit performance.
SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
- Estimated R&D budget.
- Research facilities and staff.
- New technologies, systems and applications in development.
SECTION X: COLLABORATIVE ARRANGEMENTS
- Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
- Terms of collaborative agreements and specific products involved.
SECTION XI: STRATEGIC DIRECTION
- Specific business, new product development and marketing strategies.
- Anticipated acquisitions, joint ventures and divestitures.

Fill The Form For Sample Request

Full Name *

Business Email *

E-mail *

Country * Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available